SOUTH
SAN FRANCISCO, Calif., May 30, 2024
/PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today
announced that Raul Rodriguez, the
company's president and CEO, will present a company overview at the
Jefferies Global Healthcare Conference on Thursday, June 6, 2024 at 9:30 am ET in New York,
NY.
To access the live webcast or archived recording, visit the
Investor Relations section of the company's website at
www.rigel.com. Please connect to Rigel's website prior to the start
of the live webcast to allow for any software downloads.
About Rigel
Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL)
is a biotechnology company dedicated to discovering, developing and
providing novel therapies that significantly improve the lives of
patients with hematologic disorders and cancer. Founded in 1996,
Rigel is based in South San Francisco,
California. For more information on Rigel, the Company's
marketed products and pipeline of potential products, visit
www.rigel.com.
Contact for Investors & Media:
Investors:
Rigel Pharmaceuticals, Inc.
650.624.1232
ir@rigel.com
Media:
David
Rosen
Argot Partners
Phone: 212.600.1902
Email: david.rosen@argotpartners.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/rigel-to-present-at-the-jefferies-global-healthcare-conference-302158864.html
SOURCE Rigel Pharmaceuticals, Inc.
